Collegium Pharmaceutical, Inc. COLL

US Pharmaceuticals

$24.35 ▼ -1.46% ($-0.36)

Open $24.34

Prev Close $24.71

Day Range $24.25 – $24.96

52W Range $21.43 – $50.79

Market Cap $767.87M

P/E (TTM) 16.06

Beta 0.72

EPS (TTM) $1.11

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-05-07
Shares Out.	32,560,000
Website	collegiumpharma.com/ ↗
Phone	17817133699
Employees	423
Revenue	$216.3M
Gross Profit	$125.4M
Net Income	$21.8M
Free Cash Flow	$336.3M
Total Assets	$2.10B
Total Liabilities	$1.80B
Equity	$296.4M

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Collegium Pharmaceutical, Inc. is a publicly traded company under the ticker symbol COLL on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.